Critical building blocks for the response to HIV were made until 2012 despite a series of political, social and financial challenges.
• Addressing structural barriers for KP to access services, and identifying and targeting KPs at higher risk;
• Strengthening the network of public facilities, NGOs and general practitioners and introducing a case management approach to assist KPs and other clients with unknown HIV status, HIV-negative clients and newly diagnosed clients to access the health services across the continuum to increase the number of people testing for HIV and to reduce loss to follow-up in both prevention and treatment;
• Increasing the availability of HIV testing and counselling services for KPs, clients of female sex workers (FSW), and other populations at risk, and raising the demand for timely testing including expansion of outreach and client-initiated voluntary counselling and testing (VCT) services;
• Monitoring and maximising retention from HIV diagnosis to ART initiation and expanding quality HIV laboratory services, especially viral load;
• Prioritising integration of HIV and related services in high-burden areas;
• Increasing the proportion of PLHIV receiving testing and treatment at public facilities by improving human resources and increasing public facilities providing these services to ensure sustainability;
• Obtaining intelligence and tailoring services in hard-to-reach/under-served areas; • Strengthening planning, monitoring, and coordination capacity especially at regional levels.
Introduction: Myanmar in context
Myanmar is classified as a lower-middle-income and a least developed country in Southeast Asia with a population of 51.4 million [1] . Administratively, the country is composed of NayPyiTaw union territories and 14 states and regions. More than 60 years of internal conflict, military rule, and sanctions from international governments have affected the country's economic growth and development. The total health expenditure in Myanmar, 1.7-2.3% of its gross domestic product (GDP) between 2001 and 2014, is among the lowest in the Asia Pacific region.
Myanmar detected its first case of HIV from a person who injected drugs in 1988 and the first AIDS case was diagnosed in 1991. Between 1990 and 2000, prevalence remained elevated in high-risk groups, notably people who inject drugs (PWID) peaking alarmingly at 74.3% in 1993, men who have sex with men (MSM), and female sex workers (FSWs), peaking at 38% in 2000. Over the following decade (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) , the epidemic reached clients of sex workers and partners of PWID, and female sexual partners of men who are from key population groups, leading to vertical transmission of HIV to their newborns. National level HIV prevalence was estimated to be 28.5% among PWID in 2014, and 14.6% among FSW and 11.6% among MSM in 2015 according to the AIDS Epidemic Model (AEM) based on the Integrated Bio-Behavioural Surveillance (IBBS) surveys among key populations and HIV sentinel surveillance (HSS). According to the AEM in 2015, the highest proportion of new infections was among PWID (28%) from the use of contaminated injecting equipment, followed by 'low-risk' women (24%), and FSW clients (23%). New infections in 2015 were estimated to be 11,763, approximately 32 new infections daily, according to Spectrum 2016. The overall HIV epidemic in Myanmar seems to be declining with HIV prevalence among adults, 15 years and older, estimated to be less than 0.6% nationally. There were an estimated 224,795 people living with HIV (PLHIV) including those aged under 15, one-third of whom were female. The severity of the HIV epidemic in Myanmar varies widely by geographical area. HIV prevalence in some locations in Myanmar is among the highest in the Asia-Pacific region. Approximately 65% of KPs are estimated to be in five regions and states (Mandalay, Yangon, Sagaing, Kachin and Shan North), largely in urban areas. In Yangon, among MSM, the HIV prevalence at 26.6% is the highest in a specific geographical location in the Asia-Pacific region, higher than Bangkok at 24.4% in 2012. Whereas in some townships in Kachin and Shan North, nearly one in two PWID who participated in the 2014 IBBS survey tested HIV positive.
In financing the HIV response, Myanmar has received external funding support since 2002, albeit with some challenges. In 2003, the Fund for HIV in Myanmar (FHAM) was established by Norway, UK, Sweden and the Netherlands. The Three Diseases Fund (3DF), a multi-donor trust fund was formed in 2006 to replace the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) grant upon withdrawal from the country. The FHAM was merged into the new fund to provide much needed assistance for HIV, tuberculosis (TB) and malaria. The 3DF then transitioned into the Three Millennium Development Goal Fund (3MDG), which was launched in 2012 by seven bilateral donors (Australia, Denmark, European Union, Sweden, Switzerland, United Kingdom and USA) to support maternal, newborn and child health (MNCH), HIV, TB and malaria, and health systems strengthening. Following the termination of a previous grant, the GFATM grant Round 9 was re-established in Myanmar in 2011 and continued as the New Funding Model (NFM) through 2016 [2] . As of 2015, GFATM is the single largest financing source covering 50% of the HIV response in Myanmar. Its funding beyond 2016 is being explored. Responding to HIV is a national priority, as evidenced by increasing domestic funding. The proportion of Government spending as part of total HIV expenditures increased from 2% (US$ 0.6 million) in 2012 to 7.7% (US$ 4.1 million) in 2013, and even further to 12.3% (US$ 10.4 million) in 2015 [3] . The change from military rule to a civilian government in 2011 brought increased support from both government and donors. A newly established government in April 2016 will potentially bring additional increased external resources to health and development in Myanmar.
This article reviews and document Myanmar's response to the HIV epidemic over the last decades (1990-2016) and how it is moving towards the goal of ending the AIDS epidemic as a public health threat.
Review methods
The review is based on a literature review of available data, documents and reports (published and unpublished), validated with key partners (National AIDS Programme, WHO, and UNAIDS).
Review findings
This article describes Myanmar's response to HIV of nearly three decades in a nutshell, and the continuous efforts taken to strengthen policy and strategic directions, overcome challenges and attempts to reach the goal of ending AIDS by 2030. In particular, this review focuses on the building blocks of the country's response through four phases (Table 1) .
Response: 1991-2000
Government recognition of HIV An inter-sectoral National AIDS Committee chaired by the Minister of Health was established in 1989 and provided oversight. A short term plan for the prevention and control of HIV transmission was launched that same year. The first national medium-term plan for prevention and control of HIV/AIDS was formulated in 1991, followed by a joint plan by the National AIDS Programme (NAP), Ministry of Health, and the United Nations Development Programme (UNDP) in 1994. In the late 1990s, several collaborative projects were undertaken with the support of UN entities and bilateral agencies to enhance efforts for HIV prevention and care [4] . A limited number of international non-governmental organisations (INGOs) worked directly, or through a few national civil society organisations, with key populations such as PWID and FSW.
Information, education and communication (IEC) across different sectors
A multilingual public education campaign was adopted as a multi-sectoral approach by several Ministries. HIV prevention, in particular IEC for key populations with HIV/AIDS and peer education for PWIDs were the mainstay of the national programme. Counselling, STI education and treatment were provided to FSWs by 45 STI/AIDS teams in priority townships and via NGOs. HIV testing and confirmation was performed only at governmentassigned laboratories, leading to delays in providing test results.
HIV sentinel surveillance
The national programme started systematic surveillance among key population groups in selected geographical areas in 1991. Biennial HIV sentinel surveillance (HSS) [5] Interventions targeting PWID and FSW were expanded by NGOs and INGOs. Needle and syringe distribution grew five-fold from 2005, from 545,000 needles and syringes to nearly 7 million distributed by 2010. In addition, 1101 PWID were receiving methadone [8] . Services for PWID were geographically concentrated in only three areas (Shan state, Kachin state and Mandalay division) as these were economic and trade zones for opium with noted higher HIV prevalence [9] .
Small scale projects for MSM initiated by NGOs and INGOs provided condoms, lubricants and other HIV prevention interventions. IEC was provided through peer outreach focusing on hard-to-reach MSM. VCCT and STI services were provided by private and public sectors.
Initially, VCCT and other HIV testing and counselling (HTC) services were provided only by the public sector and at sentinel surveillance Improved collaboration between governments, NGOs and INGOs, development partners and other stakeholders was seen. The United Nations Office for Project Services (UNOPS) and Save the Children worked closely with NAP and sub-recipients (i.e. INGOs, NGOs, general practitioners, civil societies and networks) to implement the GFATM grant. INGOs, NGOs and general practitioners provided ART, care and support for PLHIV in collaboration with the public sector. Community support groups became increasingly involved in child protection advocacy and social support, working with the Ministry of Social Welfare and civil society groups [13] .
Rapid increase of service coverage
Coverage of a range of services increased significantly in implementing NSP II with the GFATM, the government, and other sources including 3MDG, US Government, and MSF Holland during this phase.
KP outreach was expanded to achieve 67%, 53%, and 67% coverage for FSW, MSM and PWID, respectively in 2014. From 2013 to 2015, there was a 67% increase in the number of needles and syringes distributed from around 11 million to 18.5 million, equivalent to an increase from 147 to 223 units per person who injects drugs.
Coverage of ART doubled from 23.6% in 2012 to 47.4% or 106,490 PLHIV people on ART by the end of 2015 [14] . The NAP along with implementing partners increased the number of ART facilities from 147 in 2013 to 269 in 2015, with 82 public ART initiation sites, 137 public ART maintenance sites, and 50 nongovernment sites. There was a significant decline in the number of HIV-related deaths from 15,601 in 2011 to 9675 in 2015 [15] . Out of the 106,490 patients (adults and children) who were on ART, only 9700 had received a viral load test in 2015.
Provider-initiated testing and counselling (PICT) for pregnant women was progressively integrated in ANC settings nationwide. HIV testing coverage among pregnant women and ARV coverage among HIV-positive pregnant women to reduce mother-to-child transmission (MTCT) were 67.2% and 86.0%, respectively in 2015 [14] . In 2015, 3923 HIV-positive pregnant women received ARVs to reduce the risk of MTCT (2400 received Option B and 1523 Option B+). In 2015, 2169 exposed infants were born and started on nevirapine (NVP) prophylaxis, suggesting that about 46% of all infants born to HIV-positive women were lost to follow-up. The number of infants who received an HIV test within 2 months of birth to ensure early infant diagnosis (EID) was 801 (773 negative, 25 HIV-positive and three indeterminate), suggesting a large loss to follow-up among potentially exposed infants.
B vaccination, hepatitis C testing, condoms and educational materials [17] .
General practitioners were also involved in HIV diagnosis, treatment of opportunistic infections, care for TB and HIV co-infection, ART maintenance, and adherence to the treatment. The NSP III intends to ensure highly focused and cost efficient approaches that will provide the right interventions to the right people in the right places. New features of the NSP III include the following:
• Geographical prioritisation through categorisation of townships based on epidemic burden and risk of new infections;
• Differentiation of service delivery approaches for higher impact to reach priority populations and expedite their access to services;
• Continuum of HIV prevention, testing, care and treatment services including strengthened partnerships between the public, INGOs, NGOs, community and private sectors;
• Prioritising integration/co-location of services in highburden areas;
• Transition to increased public sector management, especially of ART; and
• Streamlined programme costs to ensure savings and efficiency gains from economies of scale and scope.
Regarding the geographical prioritisation, existing data were analysed through a process of triangulating population size estimates of priority populations, known HIV prevalence, reported HIV-positive and TB/HIV-positive data, number of PLHIV on ART and reported PMTCT/HIV-positive data. This analysis resulted in the classification of 85 high-burden townships; 151 mediumburden townships; and 94 low-burden townships. It was estimated that between 63% and 77% of key populations were in highburden townships, while 76% of adult PLHIV and 78% of adults on ART resided in high-burden townships. Between 19% and 31% of key populations and adults on ART were in medium-burden townships and only up to 6% of key populations were within low-burden townships.
Each township plans to implement differentiated service delivery approaches. For prevention, in high-burden townships, government and INGO and NGO partners will jointly scale up programmes that are relevant to the needs of the key population through the Key Population Service Centre approach, which includes drop-in-centres, mobile outreach units, peer educators, as well as internet and smart phone-based applications, among other initiatives. Medium-and low-priority townships will receive a standardised basic programme package, consisting mainly of IEC, condom distribution, prevention and HIV testing information, and HIV awareness raising through activities such as World AIDS Day campaigns.
HIV testing will be optimised through intensifying different HIV testing approaches to target different priority populations. Specifically, community HTC for KPs and VCCT for other vulnerable populations including FSW clients, KP partners, and unreached KPs will be prioritised in high-burden areas while PITC for PMTCT and TB/HIV will be made available throughout the country regardless of the level of burden.
ART initiation will be focused in high-burden townships. In medium-and low-burden townships, the ART initiation service will be accessible on-site, or by referral. PMTCT services will continue to be available throughout the country. The NSP III prioritises the transition of ART services from INGOs and NGOs to the public sector. It also aims to increase community involvement in the HIV response and supports the strengthening of community systems. Providing familiarity and interactions with communities and KPs also serves to increase understanding and compassion of public sector healthcare providers towards PLHIV and KPs, ultimately reducing HIV-related stigma and discrimination.
Integrated/co-location service delivery including HTC, ART, TB/HIV and PMTCT should minimise physical referral, especially in high-burden areas, resulting in fewer loss-to-follow-up cases. Individual case monitoring and improved response systems will help to better track patients across the care continuum.
Other focus areas in the NSP III include: building infrastructure and capacity for viral load monitoring and testing, including point-of-care viral load testing in order to achieve viral suppression in ART patients; improving and speeding up treatment of TB patients who need ART; and addressing problems identified around the continued high MTCT rate.
Ultimately NSP III interventions were selected based on those that are most likely to achieve results and impact the epidemic. With rigorous programme and cost-efficiency reviews, the new NSP has identified up to US$150 million in savings for the duration of the NSP from 2016 to 2020. Through these evidence-informed, results-oriented, innovative approaches, Myanmar strives to reach its goals to eliminate HIV as a public health threat, as part of a wider health agenda that includes providing universal access to health.
